-
11.
公开(公告)号:US20220387613A1
公开(公告)日:2022-12-08
申请号:US17824293
申请日:2022-05-25
Applicant: Pfizer Inc.
Inventor: Annaliesa Sybil Anderson , Caitlyn Gallagher , Jianxin Gu , Isis Kanevsky , Jin-Hwan Kim , Justin Keith Moran , Suddham Singh , Naveen Surendran
Abstract: The present invention relates to new conjugated capsular saccharide antigens (glycoconjugates), immunogenic compositions comprising said glycoconjugates and uses thereof.
-
公开(公告)号:US11260119B2
公开(公告)日:2022-03-01
申请号:US16534457
申请日:2019-08-07
Applicant: Pfizer Inc.
Inventor: Robert G. K. Donald , Annaliesa Sybil Anderson , Laurent Oliver Chorro , Jianxin Gu , Jin-Hwan Kim , Srinivas Kodali , Jason Arnold Lotvin , Justin Keith Moran , Rosalind Pan , Avvari Krishna Prasad , Mark Edward Ruppen , Suddham Singh , Ling Chu , Scott Ellis Lomberk , Karen Kiyoko Takane , Nishith Merchant , Wei Chen
IPC: A61K39/108 , C08B37/00 , A61P31/04 , A61P37/04 , A61K39/00
Abstract: In one aspect, the invention relates to an immunogenic composition comprising modified O-polysaccharide molecules derived from E. coli lipopolysaccharides and conjugates thereof. Multivalent vaccines may be prepared by combining two or more monovalent immunogenic compositions for different E. coli serotypes. In one embodiment, the modified O-polysaccharide molecules are produced by a recombinant bacterium that includes a wzz gene.
-
13.
公开(公告)号:US11090375B2
公开(公告)日:2021-08-17
申请号:US16899738
申请日:2020-06-12
Applicant: Pfizer Inc.
Inventor: Emilio Anthony Emini , Wendy Jo Watson , Avvari Krishna Prasad , Mingming Han , Jin-Hwan Kim , Jianxin Gu , Yu-ying Yang , Rajesh Kumar Kainthan , David Cooper , Michael William Pride , Kathrin Ute Jansen
Abstract: The present invention relates to new immunogenic compositions comprising conjughated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.
-
公开(公告)号:US20170224804A1
公开(公告)日:2017-08-10
申请号:US15347034
申请日:2016-11-09
Applicant: PFIZER INC.
Inventor: Jianxin Gu , Jin-hwan Kim , Avvari Krishna Prasad , Yu-ying Yang
IPC: A61K39/095 , A61K39/09
CPC classification number: A61K39/095 , A61K39/092 , A61K45/06 , A61K47/64 , A61K47/6415 , A61K47/646 , A61K2039/6037 , A61K2039/6068 , A61K2039/627
Abstract: The invention provides eTEC linked glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a (2-((2-oxoethyl)thio)ethyl)carbamate (eTEC) spacer, immunogenic compositions comprising such glycoconjugates, and methods for the preparation and use of such glycoconjugates and immunogenic compositions.
-
公开(公告)号:US20150216996A1
公开(公告)日:2015-08-06
申请号:US14420822
申请日:2013-08-12
Applicant: PFIZER INC.
Inventor: Jianxin Gu , Jin-hwan Kim , A. Krishna Prasad , Yu-ying Yang
CPC classification number: A61K39/095 , A61K39/092 , A61K45/06 , A61K47/64 , A61K47/6415 , A61K47/646 , A61K2039/6037 , A61K2039/6068 , A61K2039/627
Abstract: The invention provides eTEC linked glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a (2-((2-oxoethyl)thio)ethyl)carbamate (eTEC) spacer, immunogenic compositions comprising such glycoconjugates, and methods for the preparation and use of such glycoconjugates and immunogenic compositions.
Abstract translation: 本发明提供了包含通过(2 - ((2-氧代乙基)硫基)乙基)氨基甲酸酯(eTEC)间隔物共价结合载体蛋白质的糖的eTEC连接的糖缀合物,包含这种糖缀合物的免疫原性组合物,以及制备和使用 这样的糖缀合物和免疫原性组合物。
-
公开(公告)号:US20240033367A1
公开(公告)日:2024-02-01
申请号:US18330144
申请日:2023-06-06
Applicant: Pfizer Inc.
Inventor: Jianxin Gu , Rajesh Kumar Kainthan , Jin-Hwan Kim , Avvari Krishna Prasad , Yu-Ying Yang
CPC classification number: A61K47/6415 , A61K39/092 , A61K47/646 , A61K2039/6037
Abstract: The present invention relates generally to glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a spacer containing ((2-oxoethyl)thio)). In an aspect the invention provides oxo-eT linked glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a ((2-oxoethyl)thio) spacer having the formula (I):
wherein:
A is a group (C═X)m wherein X is S or O and m is 0 or 1;
B is a bond, O, or CH2; and when m is 0, B can also be (C═O);
R is a C2-C16 alkylene, C2-C16 heteroakylene, NH—C(═O)—C2-C16 alkylene, or NH—C(═O)—C2-C16 heteroakylene, wherein said alkylene and heteroalkylene are optionally substituted by 1, 2 or 3 groups independently selected from COOR′ where R′ is selected from H, methyl, ethyl or propyl.
The invention further relates to immunogenic compositions comprising such glycoconjugates, and to methods for the preparation and use of such glycoconjugates and immunogenic compositions.-
公开(公告)号:US11707529B2
公开(公告)日:2023-07-25
申请号:US16852697
申请日:2020-04-20
Applicant: Pfizer Inc.
Inventor: Jianxin Gu , Rajesh Kumar Kainthan , Jin-Hwan Kim , Avvari Krishna Prasad , Yu-Ying Yang
CPC classification number: A61K47/6415 , A61K39/092 , A61K47/646 , A61K2039/6037 , A61K2039/627 , C07K1/1077
Abstract: The present invention relates generally to glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a spacer containing ((2-oxoethyl)thio)). In an aspect the invention provides oxo-eT linked glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a ((2-oxoethyl)thio) spacer having the formula (I):
wherein:
A is a group (C═X)m wherein X is S or O and m is 0 or 1;
B is a bond, O, or CH2; and when m is 0, B can also be (C═O);
R is a C2-C16 alkylene, C2-C16 heteroakylene, NH—C(═O)—C2-C16 alkylene, or NH—C(═O)—C2-C16 heteroakylene, wherein said alkylene and heteroalkylene are optionally substituted by 1, 2 or 3 groups independently selected from COOR′ where R′ is selected from H, methyl, ethyl or propyl.
The invention further relates to immunogenic compositions comprising such glycoconjugates, and to methods for the preparation and use of such glycoconjugates and immunogenic compositions.-
公开(公告)号:US20220168410A1
公开(公告)日:2022-06-02
申请号:US17672126
申请日:2022-02-15
Applicant: Pfizer Inc.
Inventor: Robert G.K. Donald , Annaliesa Sybil Anderson , Laurent Oliver Chorro , Jianxin Gu , Jin-Hwan Kim , Srinivas Kodali , Jason Arnold Lotvin , Justin Keith Moran , Rosalind Pan , Avvari Krishna Prasad , Mark Edward Ruppen , Suddham Singh , Ling Chu , Scott Ellis Lomberk , Karen Kiyoko Takane , Nishith Merchant , Wei Chen
IPC: A61K39/108 , C08B37/00 , A61P31/04 , A61P37/04
Abstract: In one aspect, the invention relates to an immunogenic composition comprising modified O-polysaccharide molecules derived from E. coli lipopolysaccharides and conjugates thereof. Multivalent vaccines may be prepared by combining two or more monovalent immunogenic compositions for different E. coli serotypes. In one embodiment, the modified O-polysaccharide molecules are produced by a recombinant bacterium that includes a wzz gene.
-
公开(公告)号:US20220016229A1
公开(公告)日:2022-01-20
申请号:US17312185
申请日:2019-12-09
Applicant: Pfizer Inc.
Inventor: Avvari Krishna Prasad , Jianxin Gu , Jin-Hwan Kim , Suddham Singh
Abstract: The present invention relates to new glycoconjugates comprising Streptococcus pneumoniae capsular saccharide antigens and uses thereof. Glycoconjugates of the present invention will typically comprise 2 or more saccharides antigens conjugated to the same molecule of the protein carrier. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using immunogenic compositions comprising said novel glycoconjugates.
-
公开(公告)号:US20210023193A1
公开(公告)日:2021-01-28
申请号:US17060337
申请日:2020-10-01
Applicant: Pfizer Inc.
Inventor: Jianxin Gu , Rajesh Kumar Kainthan , Jin-Hwan Kim , Avvari Krishna Prasad , Yu-Ying Yang
IPC: A61K39/09 , A61K39/385 , A61K39/39
Abstract: The invention relates to activated Streptococcus pneumoniae serotype 10A, 22F or 33F polysaccharides and processes for their preparation. The invention also relates to immunogenic conjugates comprising Streptococcus pneumoniae serotype 10A, 22F or 33F polysaccharides covalently linked to a carrier protein, processes for their preparation and immunogenic compositions and vaccines comprising them.
-
-
-
-
-
-
-
-
-